À propos de Julien
- Reorganising the business or driving strategic transformation and organic growth, and
- Buying, selling or separating a business (due diligence, PMI, carve-out, synergies, Day-1 readiness).
Strategic transformation & PMO
- Lead transformation and reorganisation programmes, translating strategy into TOMs, org structures, roadmaps and Day-1 readiness.
- Run PMO in cross-functional setups: scope, plans, critical path, RAID, KPIs, SteerCos and workstream governance.
- Drive change and communication: stakeholder mapping, comms and training with local leaders.
Transactions (DD, PMI & carve-out)
- Deliver financial / commercial / operational DD: performance and growth drivers, pricing/mix, customer and market views.
- Shape PMI: integration blueprint, synergy view, value-capture and tracking.
- Support carve-outs / separations: standalone cost base, operating model, Day-1 and transition plans.
Typical missions & deliverables
- Transformation / PMO lead for re-orgs or strategic programmes; M&A support from DD through PMI / carve-out.
- Project charters, TOM and org designs, implementation roadmaps, KPI / risk dashboards, SteerCo decks and Day-1/100 plans.
How I work
- Learn fast, stay outcome-focused and don’t give up on complex problems.
- Structured, hands-on, strong at coordination and stakeholder management; clear communication with senior leaders and local teams.
- Comfortable in multi-country, regulated and PE-backed environments; known for reliability, follow-through and a get-it-done attitude.
Anglais
Bilingue ou natif
Français
Bilingue ou natif
Espagnol
Capacité professionnelle complète
Allemand
Notions
Expériences
- BoehringerIngelheim -PMOFreelance Consultant - Project ManagerINDUSTRIE PHARMACEUTIQUEjuin 2024 - octobre 2025 (1 an et 4 mois)Vienna, Autriche
Focus areas
Strategic transformation, target operating model design, reorganisation and optimisation, go-to-market plans, strategic commercial initiatives, and change management & communications.Key achievements
- TA / asset-team operating model: Led the PMO for a regional transformation (c. 3,000 FTEs, 14+ countries) from siloed functions to cross-functional TA / asset teams; translated strategy into a target operating model (roles, decision rights, country archetypes) and enabled Day-1 readiness across markets.
- HQ optimisation / restructuring: Designed and implemented process optimisation for the HQ Human Pharma division using activity/process heatmaps, workshops and cost/FTE analysis, delivering ~€1m annual savings and a 4.5 FTE reduction while improving workflow effectiveness.
- Emergency operating model (product-to-patient): Project managed a cross-functional team to co-design a supply chain emergency operating model for product-to-patient delivery, defining end-to-end processes and governance and saving ~€3m annually.
- GTM — Commercial acceleration (diabetes brand): Project managed a GTM acceleration programme across 14+ countries targeting +2% market share; simplified content and messaging, coordinated rollout plans, and launched a “Champions League” competition (~500 MSRs, ~50 DSMs) to boost competitiveness and sales growth.
Key responsibilities
- Lead PMO delivery: build integrated plans and critical path, manage RAID/dependencies and decision logs, and own SteerCo / governance reporting.
- Drive cross-functional, multi-country execution across HQ, regional and local teams, ensuring alignment, handovers and follow-through.
- Translate leadership vision into target operating models and implementation plans (structures, roles, processes, KPIs and ways of working).
- Set up and run governance and change management.
- Monitor progress, outcomes and KPIs.
- PwCManager Strategy & Transaction AdvisoryCONSEIL & AUDITjanvier 2020 - mai 2024 (4 ans et 4 mois)Zurich, SuisseManager Strategy & Transaction Advisory Services: Chile (full time) & Switzerland (contractor basis)Advised PE and corporate clients on 10+ engagements across buy-side, sell-side, carve-out and integration projects.
Key achievements
- Performed a synergy assessment quantified c. $1m p.a. recurring revenue and c. $0.5m p.a. cost savings (~4 FTEs), assessing cross-sell opportunities and duplicate back-office roles and shaping the post-merger integration plan.
- Led vendor due diligence for a European electronics distributor (€300m deal value), analyzing 150k+ SKUs across 10+ countries to explain performance and growth drivers (volume, pricing, mix, margins) and identifying 13+ EBITDA adjustments (~€12m) to support normalised earnings for valuation.
- Supported major carve-outs including Sandoz from Novartis (listing readiness) and a power utility separation, preparing standalone financials and cost-base benchmarks to enable Day 1 readiness and business continuity.
- Conducted in-depth market and competitive analysis for a medical equipment company (~$50m deal value) and built a data-driven performance view by product, business line and customer to identify growth opportunities and inform integration priorities for the PE client.
Key responsibilities
- Lead due diligence engagements with small teams (2–5) and multidisciplinary stakeholders.
- Analyse performance and forecasts, normalise earnings, and evaluate standalone P&Ls, carve-out impacts and synergies.
- Build Day 1/100 plans and synergy tracking; support governance cadence and decision-making.
- Deliver market/competitive assessments and business plan reviews with decision-ready output
- EY ParthenonManager in Strategy & Transaction Advisory ServicesCONSEIL & AUDITmai 2016 - décembre 2019 (3 ans et 7 mois)Sydney, Australie
Strategy & Transaction Advisory Services (senior consultant and Manager) - Sydney
Managed +15 buy and sell-side due diligence engagements, IPO readiness and, separation & integration, commercial insights engagements; led and coached teams (2-5), coordinated multidisciplinary stakeholders across SaaS, retail, and health & wellnessKey achievements
- Co-led buy-side due diligence for Laser Clinics Group (~80 clinics; ~$51m EBITDA), using cohort analysis to assess ramp-up run-rate (Year 3) and delivering buy-side pro forma adjustments; identified ~$1m earnings reduction supporting valuation for PE client.
- Conducted commercial due diligence on a legal information SaaS platform, built recurring revenue and customer bridge analyses and assessed market size/growth, quantifying ~70% price-driven organic growth and worked with management to refine the business plan, forecast model and overall strategy.
- Performed a strategic separation for an outsourcing division (~$40m EBITDA), building a ~$25m standalone cost base through functional headcount/cost review and benchmarking against similar-sized businesses, supporting standalone readiness and Day 1 planning.
- Delivered a synergy assessment for the integration of merged HR/payroll software companies, quantifying c. $8m of synergies (duplicate roles/run-rate savings) and co-designing the integration blueprint and post-close synergy tracking
Recommandations
Soyez le premier à recommander Julien
Contribuez à la réussite de ce freelance en partageant votre expérience de collaboration avec lui.
Ces profils de freelance correspondent également à vos critères
Agatha Frydrych
Backend Java Software Engineer
4.7
(3)
2
Baptiste Duhen
Fullstack developer
4.6
(4)
5
Amed Hamou
Senior Lead Developer
4
(2)
7
Audrey Champion
Web developer
4.3
(3)
4
Formations
- Master in FinanceCARLOSIII,MADRID2012Master in Finance
- Bachelor of ManagementUTS Sydney2010Bachelor of Management